Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Lexaria Bioscience Corp.
| Metric | Lexaria Bioscience Corp. LEXX, LEXXWHealthcare |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $705,923 |
| Net income (latest) | −$12M |
| Operating margin | −1683.0% |
| Net margin | −1686.0% |
| Return on equity | −398.1% |
| Return on assets | −285.1% |
| Return on capital (ROCE) | −443.0% |
| Debt / equity | 0.53× |
| Revenue growth (YoY) | 52.0% |
| Altman Z″ (distress) | -63.57 |
| Accruals / assets | −34.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.